[Edaily Reporter Kim Se-yeon ] DB INSURANCE(005830)has once again this year presented scholarships to Chungju Seongsim School, a special education institution for the hearing impaired. This marks the 14th consecutive year of the program, with cumulative scholarship donations totaling approximately 340 million won. DB INSURANCE presented a scholarship of 30 million won to Chungju Seongsim School on the 13th. (Photo: DB INSURANCE) DB INSURANCE announced on the 29th that it had presented a scholarship of 30 million won to Chungju Seongsim School on the 13th to support the students’ educational environment. This scholarship is scheduled to be used for educational expenses for students facing financial difficulties and to support the operation of the school’s baseball team. DB INSURANCE has been providing scholarships annually since signing a sponsorship agreement with Chungju Seongsim School in 2013. Including this year’s donation, the cumulative amount of scholarship funds provided stands at approximately 340 million won. In addition to providing scholarships, the company has engaged with students through various programs, including volunteer activities by employees of the North Chungcheong Business Unit to improve the school environment, donations of supplies for the baseball team, and events inviting students to watch DB Inc. basketball games. The company also continues to support students living in difficult circumstances by providing various daily necessities. A representative from DB INSURANCE stated, “We hope that our 14-year partnership with Chungju Seongsim School will serve as a small source of strength for the students’ growth,” adding, “We will continue our social contribution activities, fulfilling our corporate social responsibility and growing together with the local community.”
Business leaders from South Korea and Brazil have agreed to expand cooperation across a wide range of strategic industries, from critical mineral supply chains to artificial intelligence (AI), biotech…
Ingenia Therapeutics (Ingenia), an innovative antibody drug developer set to list on KOSDAQ, has brought a treatment for chronic kidney disease (CKD) to the negotiating table with a global big pharma …
AHNLAB,INC.(053800)announced preliminary financial results on the 29th, reporting consolidated revenue of 130.4 billion won and operating profit of 7.3 billion won for the first half of this year.
…